biotech firms expanding glp-1 use beyond diabetes and obesity 2025

biotech firms expanding glp-1 use beyond diabetes and obesity 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 SUSTAINABLE GLP-1 DRUG DELIVERY: FUTURE-PROOFING

Name: biotech firms expanding glp-1 use beyond diabetes and obesity 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 SUSTAINABLE GLP-1 DRUG DELIVERY: FUTURE-PROOFING
Brand: www.himachallive.in
SKU: 41948850086
Price: 26.34 USD
Availability: InStock
Rating: 4.855 (12 reviews)

SKU: 41948850086

4.9

USD26.34 USD64.34

Pay in 4 interest-free payments of $6.58 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 9 - Aug 14

Description

Studies in ALS models have also indicated potential beneficial effects of GLP-1 receptor agonism

NCT03287076 ) performed in patients with ischemic stroke to evaluate the impact of exenatide therapy on various mechanistic outcomes such as CBF velocity, endothelial function, inflammation, and post-stroke hyperglycemia